# Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer

> **NCT04689425** · PHASE3 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Umbilical cord blood mononuclear cell gel（MNC）
- **DRUG:** The platelet rich plasma（PRP）

## Key facts

- **NCT ID:** NCT04689425
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-30
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04689425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04689425, "Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04689425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*